Bill Title: Amends the Prior Authorization Reform Act. Provides that notwithstanding any other provision of law, a health insurance issuer or a contracted utilization review organization may not require a prior authorization for drug therapies approved by the U.S. Food and Drug Administration for the treatment of hereditary bleeding disorders any more frequently than 6 months or the length of time the prescription for that dosage remains valid, whichever period is shorter. Effective January 1, 2026.

Spectrum: Moderate Partisan Bill (Republican 9-1)

Status: (Enrolled) 2024-05-15 - Passed Both Houses [HB4055 Detail]

Text: Latest bill text (Enrolled) [HTML]

---

Sponsors

Name	Type	Sponsorship	District	Financial	Encyclopedia	Biography
Representative William Hauter [R]	Primary	Sponsored Bills	HD-087	FollowTheMoney	Ballotpedia	VoteSmart
Representative Martin McLaughlin [R]	Cosponsor	Sponsored Bills	HD-052	FollowTheMoney	Ballotpedia	VoteSmart
Representative Paul Jacobs [R]	Cosponsor	Sponsored Bills	HD-118	FollowTheMoney	Ballotpedia	VoteSmart
Representative Brandun Schweizer [R]	Cosponsor	Sponsored Bills	HD-104	FollowTheMoney	Ballotpedia	VoteSmart
Representative Jed Davis [R]	Cosponsor	Sponsored Bills	HD-075	FollowTheMoney	Ballotpedia	VoteSmart
Representative Kevin Schmidt [R]	Cosponsor	Sponsored Bills	HD-114	FollowTheMoney	Ballotpedia	N/A
Representative Jason Bunting [R]	Cosponsor	Sponsored Bills	HD-106	FollowTheMoney	Ballotpedia	N/A
Representative Patrick Sheehan [R]	Cosponsor	Sponsored Bills	HD-037	FollowTheMoney	Ballotpedia	N/A
Representative Dave Severin [R]	Cosponsor	Sponsored Bills	HD-116	FollowTheMoney	Ballotpedia	VoteSmart
Senator David Koehler [D]	Primary	Sponsored Bills	SD-046	FollowTheMoney	Ballotpedia	VoteSmart

Social Comments on IL HB4055